These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 7728297

  • 1. In-vitro effect of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors on non-hepatic LDL receptor activity: evidence of lack of stimulatory effect of pravastatin.
    Pedreño J, Sánchez JL, Zambón D, Ros E.
    Coron Artery Dis; 1994 Dec; 5(12):971-7. PubMed ID: 7728297
    [Abstract] [Full Text] [Related]

  • 2. Abnormal regulation of the LDL-R and HMG CoA reductase genes in subjects with familial hypercholesterolemia with the "French Canadian mutation".
    Yu L, Qiu S, Genest J.
    Atherosclerosis; 1996 Jul; 124(1):103-17. PubMed ID: 8800498
    [Abstract] [Full Text] [Related]

  • 3. Effects of different inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, pravastatin sodium and simvastatin, on sterol synthesis and immunological functions in human lymphocytes in vitro.
    Kurakata S, Kada M, Shimada Y, Komai T, Nomoto K.
    Immunopharmacology; 1996 Aug; 34(1):51-61. PubMed ID: 8880225
    [Abstract] [Full Text] [Related]

  • 4. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase.
    Cohen LH, van Vliet A, Roodenburg L, Jansen LM, Griffioen M.
    Biochem Pharmacol; 1993 Jun 09; 45(11):2203-8. PubMed ID: 8517861
    [Abstract] [Full Text] [Related]

  • 5. Relative induction of mRNA for HMG CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells.
    Morikawa S, Umetani M, Nakagawa S, Yamazaki H, Suganami H, Inoue K, Kitahara M, Hamakubo T, Kodama T, Saito Y.
    J Atheroscler Thromb; 2000 Jun 09; 7(3):138-44. PubMed ID: 11480454
    [Abstract] [Full Text] [Related]

  • 6. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
    Lennernäs H, Fager G.
    Clin Pharmacokinet; 1997 May 09; 32(5):403-25. PubMed ID: 9160173
    [Abstract] [Full Text] [Related]

  • 7. Pravastatin: a new drug for the treatment of hypercholesterolemia.
    Jungnickel PW, Cantral KA, Maloley PA.
    Clin Pharm; 1992 Aug 09; 11(8):677-89. PubMed ID: 1511541
    [Abstract] [Full Text] [Related]

  • 8. Reversal of cyclosporine-inhibited low-density lipoprotein receptor activity in HepG2 cells by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    al Rayyes O, Wallmark A, Florén CH.
    Hepatology; 1997 Apr 09; 25(4):991-4. PubMed ID: 9096609
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of propionic acid and pravastatin on HMG-CoA reductase activity in relation to forestomach lesions in the rat.
    Bueld JE, Bannenberg G, Netter KJ.
    Pharmacol Toxicol; 1996 Apr 09; 78(4):229-34. PubMed ID: 8861780
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of single administration of pravastatin sodium on hepatic cholesterol metabolism in rats.
    Fujioka T, Tsujita Y.
    Eur J Pharmacol; 1997 Apr 04; 323(2-3):223-8. PubMed ID: 9128842
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibitors of cholesterol biosynthesis increase hepatic low-density lipoprotein receptor protein degradation.
    Ness GC, Zhao Z, Lopez D.
    Arch Biochem Biophys; 1996 Jan 15; 325(2):242-8. PubMed ID: 8561503
    [Abstract] [Full Text] [Related]

  • 20. The mechanism of lack of hypocholesterolemic effects of pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in rats.
    Fujioka T, Nara F, Tsujita Y, Fukushige J, Fukami M, Kuroda M.
    Biochim Biophys Acta; 1995 Jan 03; 1254(1):7-12. PubMed ID: 7811749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.